{
    "eu_pnumber": "",
    "atc_code": "not applicable",
    "eu_aut_status": "ACTIVE",
    "eu_brand_name_current": "EU/3/00/005",
    "status_type": "a",
    "eu_od_number": "EU/3/00/005",
    "active_substance": "Gemtuzumab Ozogamicin",
    "eu_od_con": "Treatment of acute myeloid leukaemia",
    "sponsor": "Pfizer Europe MA EEIG",
    "eu_od_pnumber": "EU/1/18/1277",
    "orphan_status": "o",
    "eu_od_date": "2000-10-18",
    "eu_aut_date": "2000-10-18 00:00:00",
    "eu_aut_type_initial": "pre_2006",
    "eu_aut_type_current": "standard",
    "ema_od_number": "EMEA/OD/022/00",
    "ema_od_number_id": "22/00",
    "eu_referral": "False",
    "eu_suspension": "False",
    "ema_number_certainty": "0.75",
    "init_addressed_to_member_states": "False"
}